UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

February 13, 2019

ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934

NxStage Medical, Inc.

File No. 000-51567 - CF#37133 _____________________

NxStage Medical, Inc. submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on August 8, 2008.

Based on representations by NxStage Medical, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:

Exhibit 10.43

through January 31, 2022

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:

Brent J. Fields

Secretary

Attachments

  • Original document
  • Permalink

Disclaimer

NxStage Medical Inc. published this content on 13 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 February 2019 14:31:10 UTC